Balyasny Asset Management »

Monopar Therapeutics shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Monopar Therapeutics (MNPR) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Monopar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monopar Therapeutics held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monopar Therapeutics by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $7.5M 136k 54.79
2025-12-31 $2.1M 32k 65.30
2025-03-31 $224k 6.1k 36.41

More positions owned by Balyasny Asset Management

State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Meta Platforms Cl A Call Option (META)
Amazon Call Option (AMZN)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Warner Bros Discovery Com Ser A Put Option (WBD)
Raytheon Technologies Corp Call Option (RTX)
Select Sector Spdr Tr State Street Fin Call Option (XLFI)
Select Sector Spdr Tr State Street Ene Call Option (XLE)
Lumentum Hldgs Note 0.500% 6/1 (Principal)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)

View all positions for Balyasny Asset Management

Top funds holding Monopar Therapeutics

Henderson Group
RA Capital Management
Adage Capital Partners GP
Saturn V Capital Management
Deerfield Management Company
BlackRock
Vanguard Group
ADAR1 Capital Management
Wellington Management Company
Vanguard Capital Management
Siren
Balyasny Asset Management
TCG Crossover Management
Polar Capital Holdings
Alyeska Investment Group

View all funds holding Monopar Therapeutics